{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:32:09Z","timestamp":1793331129259,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.carrev.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T13:02:15Z","timestamp":1712408535000},"page":"70-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Is the axiom of balloon angioplasty, \u201cthe more you gain the more you lose,\u201d still true in the era of DCB with paclitaxel?"],"prefix":"10.1016","volume":"69","author":[{"given":"Patrick W.","family":"Serruys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Basavarajaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2024.04.001_bb0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.77.2.361","article-title":"Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months","volume":"77","author":"Serruys","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0735-1097(88)80046-9","article-title":"Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients","volume":"12","author":"Nobuyoshi","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0735-1097(92)90476-4","article-title":"Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model","volume":"19","author":"Schwartz","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4244\/EIJV4I1A22","article-title":"The neointimal response to stents eluting tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release","volume":"4","author":"van Beusekom","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.04.001_bb0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/eurheartj\/ehp127","article-title":"MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses","volume":"30","author":"Onuma","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.04.001_bb0030","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.CIR.84.4.1568","volume":"84","author":"Serruys","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0735-1097(94)00368-Z","volume":"25","author":"Faxon","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0040","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/01.CIR.88.4.1588","article-title":"Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial","volume":"88","author":"Serruys","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0050","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.CIR.90.3.1239","article-title":"Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty","volume":"90","author":"Foley","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0055","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/01.CIR.92.9.2463","article-title":"Intracoronary heparin delivery in humans. Acute feasibility and long-term results","volume":"92","author":"Camenzind","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.CIR.96.1.154","article-title":"Site-specific intracoronary heparin delivery in humans after balloon angioplasty. A radioisotopic assessment of regional pharmacokinetics","volume":"96","author":"Camenzind","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.04.001_bb0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4244\/EIJY15M10_01","article-title":"In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system","volume":"12","author":"Granada","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.04.001_bb0070","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jcin.2017.06.021","article-title":"The SABRE trial (Sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes","volume":"10","author":"Verheye","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.04.001_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00129784-200404040-00006","article-title":"The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions","volume":"4","author":"Waugh","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.carrev.2024.04.001_bb0080","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.04.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the Femoropopliteal artery of the leg: a systematic review and Meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2024.04.001_bb0090","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2024.04.001_bb0095","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ijcard.2014.07.224","article-title":"Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis","volume":"176","author":"Yoneyama","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvir.2018.07.025","article-title":"Comparison of biologic effect and particulate embolization after femoral artery treatment with three drug-coated balloons in healthy swine model","volume":"30","author":"Torii","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0105","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","article-title":"A prospective randomized trial comparing Sirolimus-coated balloon with paclitaxel-coated balloon in De novo small vessels","volume":"16","author":"Ninomiya","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.04.001_bb0110","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.amjcard.2010.08.032","article-title":"Farewell to a friend: Don Baim reflections","volume":"107","author":"Ron Caputo","year":"2011","journal-title":"Am J Cardiol"},{"issue":"1166\u20131175","key":"10.1016\/j.carrev.2024.04.001_bb0115","article-title":"Local, downstream, and systemic evaluation after femoral artery angioplasty with Kanshas drug-coated balloons in vitro and in a healthy swine model","volume":"34","author":"Sato","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ccd.30358","article-title":"Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial","volume":"100","author":"Greco","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.04.001_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2023.01.007","article-title":"Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: design and rationale of the SELUTION DeNovo trial","volume":"258","author":"Spaulding","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2024.04.001_bb0130","first-page":"70","article-title":"Biodegradable stents: they do their job and disappear","volume":"18","author":"Waksman","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0135","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jcin.2013.10.005","article-title":"Leaving nothing behind","volume":"6","author":"Bosiers","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.04.001_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","article-title":"From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?","volume":"33","author":"Serruys","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.04.001_bb0145","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.04.001_bb0150","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1002\/ccd.29185","article-title":"Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA\/DCB registry)","volume":"97","author":"Kitani","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.04.001_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12928-018-0537-6","article-title":"Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report","volume":"34","author":"Sato","year":"2019","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.carrev.2024.04.001_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12872-024-03709-1","article-title":"Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2024.04.001_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028413","article-title":"Single-antiplatelet treatment after coronary angioplasty with drug-coated balloon","volume":"12","author":"Cortese","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2024.04.001_bb0170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2005.09.047","article-title":"Sirolimus and paclitaxel on polymer-based drug-eluting stents: similar but different","volume":"47","author":"Wessely","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.04.001_bb0175","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.4244\/EIJ-D-23-00425","article-title":"Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model","volume":"20","author":"Aihara","year":"2024","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:22:28Z","timestamp":1750148548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S1553838924001441"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.04.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the axiom of balloon angioplasty, \u201cthe more you gain the more you lose,\u201d still true in the era of DCB with paclitaxel?","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}